Climb Bio (CLYM) Change in Cash (2020 - 2026)
Climb Bio (CLYM) posted Change in Cash of -$27.3 million for Q1 2026, down 376.55% on a QoQ basis from $9.9 million in Q4 2025, and up 53.05% year-over-year from -$17.9 million in Q1 2025.
Climb Bio (CLYM) Change in Cash (2020 - 2026) Analysis & Trends
Climb Bio's Change in Cash history runs 7 years deep, the most recent figure standing at -$27.3 million for Q1 2026.
- Quarterly Change in Cash rose 53.05% year-over-year to -$27.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.7 million (up 72.81% YoY) and the FY2025 annual result came in at -$51.5 million, down 776.15% from the prior year.
- Change in Cash was -$27.3 million for Q1 2026 at Climb Bio, down from $9.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $118.1 million in Q2 2024 and bottomed at -$77.0 million in Q3 2024.
- A 5-year average of -$2.3 million and a median of $671000.0 in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash tumbled 1462.59% — and 2024, when it soared 1391.8%.
- Climb Bio's Change in Cash stood at $7.6 million in 2022, then surged by 367.99% to $35.8 million in 2023, then plunged by 264.84% to -$58.9 million in 2024, then surged by 116.76% to $9.9 million in 2025, then tumbled by 376.55% to -$27.3 million in 2026.
- Business Quant data shows CLYM's Change in Cash at -$27.3 million in Q1 2026, $9.9 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | -27.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.33 Mn |
| Dec 31, 2025 | 9.88 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | -6.34 Mn |
| Mar 31, 2025 | -58.21 Mn |
| Dec 31, 2024 | -58.95 Mn |
| Sep 30, 2024 | -76.97 Mn |
| Jun 30, 2024 | 118.11 Mn |
| Mar 31, 2024 | 11.92 Mn |
| Dec 31, 2023 | 35.76 Mn |
| Sep 30, 2023 | 32.06 Mn |
| Jun 30, 2023 | -9.14 Mn |
| Mar 31, 2023 | -9.15 Mn |
| Dec 31, 2022 | 7.64 Mn |
| Sep 30, 2022 | 3.34 Mn |
| Jun 30, 2022 | 671,000.00 |
| Mar 31, 2022 | -14.99 Mn |
| Dec 31, 2021 | -15.90 Mn |
| Sep 30, 2021 | -36.66 Mn |
| Jun 30, 2021 | 51.57 Mn |